A literature review provided new insight into the clinical neurocognitive profile in major depressive disorder (MDD) and its relationship to cognitive deficits.
Repetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment to neuropsychiatric disorders such as major depressive disorder (MDD).
A high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.
Health experts across the country agree: we are in the midst of a mental health pandemic and have good reason to believe that this mental health crisis will lead to increased cases of depression throughout the year.
For some people, medication for depression doesn’t work and Transcranial Magnetic Stimulation, or TMS is helpful for patients that have exhausted every other option.